0QZU.L - Vertex Pharmaceuticals Incorporated

LSE - LSE Delayed price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.49
52-week change 323.26%
S&P500 52-week change 33.90%
52-week high 3353.74
52-week low 3245.50
50-day moving average 3329.89
200-day moving average 3306.38

Share statistics

Avg vol (3-month) 35.93k
Avg vol (10-day) 34.17k
Shares outstanding 5255.56M
Implied shares outstanding 6N/A
Float 8256.9M
% held by insiders 10.16%
% held by institutions 195.88%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)31 Mar 2023


Profit margin 35.40%
Operating margin (ttm)48.51%

Management effectiveness

Return on assets (ttm)16.80%
Return on equity (ttm)25.73%

Income statement

Revenue (ttm)9.21B
Revenue per share (ttm)35.87
Quarterly revenue growth (yoy)13.20%
Gross profit (ttm)5.32B
Net income avi to common (ttm)3.26B
Diluted EPS (ttm)9.48
Quarterly earnings growth (yoy)-8.20%

Balance sheet

Total cash (mrq)10.41B
Total cash per share (mrq)40.44
Total debt (mrq)789.2M
Total debt/equity (mrq)5.47
Current ratio (mrq)4.28
Book value per share (mrq)56.05

Cash flow statement

Operating cash flow (ttm)4.07B
Levered free cash flow (ttm)3.63B